At the heart of every thriving veterinary hospital is the desire to provide quality care for its patients and peace of mind for its clients.
While procedural sedation and analgesia are increasingly important tools for facilitating short, minimally-invasive outpatient procedures, traditional sedatives can put some patients at risk, making it difficult to offer the care and peace of mind you desire.

Zenalpha® is different. The novel combination of the trusted alpha-2 agonist medetomidine and vatinoxan, an innovative alpha-2 antagonist that does not cross the blood brain barrier, results in a unique balance of central and peripheral activity that offers less severe cardiovascular side effects (compared to dexmedetomidine) while maintaining the sedative and analgesic properties of medetomidine. Dogs should be monitored frequently during sedation for changes in heart rate, blood pressure, respiratory rate and body temperature.

Make Zenalpha® part of your procedural sedation protocol today.


For more information, visit www.Zenalpha.us.
Zennovation in Sedation
Start Here
to receive more information